🇺🇸 FDA
Patent

US 8048844

Preventing airway mucus production by administration of EGF-R antagonists

granted A61KA61K31/00A61P

Quick answer

US patent 8048844 (Preventing airway mucus production by administration of EGF-R antagonists) held by The Regents of the University of California expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
85
CPC classes
A61K, A61K31/00, A61P, A61P11/00, A61P11/02